10 source-based articles maintained by the HealthRX.com Editorial Team.
Showing 10 of 10 clinical reviews.
What is known and not known about combining 5-HTP with Addyi (flibanserin), why the concern is pharmacodynamic rather than pharmacokinetic, and what to verify with a prescriber or pharmacist before combining them.
Berberine inhibits CYP3A4, the same enzyme that clears flibanserin (Addyi). Learn what the pharmacokinetic data shows, what the FDA warning means for you, and how to talk to your prescriber before combining these two.
What is actually established about caffeine and flibanserin (Addyi): the metabolic pathways, the plausible but unstudied interaction, and a practical framework for assessing risk.
A guide covering the creatine-flibanserin interaction, how creatine affects serum creatinine, renal monitoring recommendations, and practical advice for women taking Addyi who also use creatine supplements.
A clinical review of the folate-flibanserin interaction: pharmacokinetics, MTHFR relevance, safe dosing windows, and monitoring guidance for women taking Addyi.
A guide to combining glycine supplements with Addyi (flibanserin), covering pharmacokinetic and pharmacodynamic interactions, dosing windows, monitoring, and safety.
A guide to the magnesium-flibanserin interaction: pharmacokinetics, safety evidence, dosing windows, and monitoring advice for women taking Addyi.
Learn whether melatonin is safe to take with Addyi (flibanserin), including pharmacokinetic and pharmacodynamic considerations, dose-separation strategies, and monitoring recommendations.
A guide to the NAC and Addyi interaction: pharmacokinetics, CYP3A4 considerations, glutathione pathways, safety monitoring, and clinical guidance for women taking flibanserin for HSDD.
St. John's Wort is a potent CYP3A4 inducer that drops flibanserin plasma levels by up to 54%, increasing hypotension and CNS depression risk. Learn the mechanism, clinical consequences, and safer alternatives.